gut
ME
ta
G
enome
A
tlas
Home
Browse
Search
Download
Help
About
Citation
LZX Lab
Introduction
Databases
dbEBV
dbRicePro
gutMEGA
iHypoxia
iCysMod
qPhos
qPTM
Tools
cPhosBac
DeepCalpain
DeepGSH
Deep-PLA
DrugCVar
dSCOPE
pCysMod
prkC-PSP
Result
taxon like '%f__Eubacteriaceae%'
Search content: Taxon = Eubacteriaceae
There are 703 entries with your keyword(s).
Condition
10-19 years / 4-9 years
10-19 years / Preweaning
10-19 years / Weaned-3 years
10-19 years / Weaning
20-29 years / 10-19 years
20-29 years / 4-9 years
20-29 years / Preweaning
20-29 years / Weaned-3 years
20-29 years / Weaning
30-39 years / 10-19 years
30-39 years / 20-29 years
30-39 years / 4-9 years
30-39 years / Preweaning
30-39 years / Weaned-3 years
30-39 years / Weaning
4-9 years / Preweaning
4-9 years / Weaned-3 years
4-9 years / Weaning
40-49 years / 10-19 years
40-49 years / 20-29 years
40-49 years / 30-39 years
40-49 years / 4-9 years
40-49 years / Preweaning
40-49 years / Weaned-3 years
40-49 years / Weaning
50-59 years / 10-19 years
50-59 years / 20-29 years
50-59 years / 30-39 years
50-59 years / 4-9 years
50-59 years / 40-49 years
50-59 years / Preweaning
50-59 years / Weaned-3 years
50-59 years / Weaning
60-69 years / 10-19 years
60-69 years / 20-29 years
60-69 years / 30-39 years
60-69 years / 4-9 years
60-69 years / 40-49 years
60-69 years / 50-59 years
60-69 years / Preweaning
60-69 years / Weaned-3 years
60-69 years / Weaning
70-79 years / 10-19 years
70-79 years / 20-29 years
70-79 years / 30-39 years
70-79 years / 4-9 years
70-79 years / 40-49 years
70-79 years / 50-59 years
70-79 years / 60-69 years
70-79 years / Preweaning
70-79 years / Weaned-3 years
70-79 years / Weaning
80-89 years / 10-19 years
80-89 years / 20-29 years
80-89 years / 30-39 years
80-89 years / 4-9 years
80-89 years / 40-49 years
80-89 years / 50-59 years
80-89 years / 60-69 years
80-89 years / 70-79 years
80-89 years / Preweaning
80-89 years / Weaned-3 years
80-89 years / Weaning
90-99 years / 10-19 years
90-99 years / 20-29 years
90-99 years / 30-39 years
90-99 years / 4-9 years
90-99 years / 40-49 years
90-99 years / 50-59 years
90-99 years / 60-69 years
90-99 years / 70-79 years
90-99 years / 80-89 years
90-99 years / Preweaning
90-99 years / Weaned-3 years
90-99 years / Weaning
> 100 years / 10-19 years
> 100 years / 20-29 years
> 100 years / 30-39 years
> 100 years / 4-9 years
> 100 years / 40-49 years
> 100 years / 50-59 years
> 100 years / 60-69 years
> 100 years / 70-79 years
> 100 years / 80-89 years
> 100 years / 90-99 years
> 100 years / Preweaning
> 100 years / Weaned-3 years
> 100 years / Weaning
Alcoholic liver disease / Alcohol dependence syndrome
Amerindians / Malawi
Ampicillin / Control
Amyotrophic lateral sclerosis / Normal
Animal-based diet / Plant-based diet
Anti-islet cell autoantibodies, Developed / Remained negative
Antibiotics, No exposure / Chronic exposure
Any breast-fed children, Mother secretor / Mother non-secretor
Asymptomatic C. difficile carriers / C. difficile infection
Asymptomatic C. difficile carriers / Normal
Atherosclerotic cardiovascular disease / Normal
Austria / China
Austria / Denmark
Austria / France
Austria / Malawi
Austria / Peru
Austria / Russia
Austria / Spain
Austria / Sweden
Austria / USA
Austria / Venezuela
Autism / Normal
Autism / Pervasive developmental disorder not otherwise specified
Autistic / Neurotypical
Babies / Adults
Beta2-1 fructan / Placebo
Breast-fed / Placebo formula
C. difficile infection / Normal
C. difficile infection patient 1, 11 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 128 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 18 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 25 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 3 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 3 days pre-FTM / Donor
C. difficile infection patient 1, 65 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 7 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 95 days post-FTM / 3 days pre-FTM
C. difficile infection patient 2, 1 days pre-FTM / Donor
C. difficile infection patient 2, 112 days post-FTM / 1 days pre-FTM
C. difficile infection patient 2, 112 days post-FTM / 27 days post-FTM
C. difficile infection patient 2, 112 days post-FTM / 3 days post-FTM
C. difficile infection patient 2, 112 days post-FTM / 41 days post-FTM
C. difficile infection patient 2, 112 days post-FTM / 7 days post-FTM
C. difficile infection patient 2, 112 days post-FTM / 81 days post-FTM
C. difficile infection patient 2, 112 days post-FTM / Donor
C. difficile infection patient 2, 27 days post-FTM / Donor
C. difficile infection patient 2, 3 days post-FTM / Donor
C. difficile infection patient 2, 41 days post-FTM / Donor
C. difficile infection patient 2, 7 days post-FTM / Donor
C. difficile infection patient 2, 81 days post-FTM / Donor
C. difficile infection patient 3, 28 days post-FTM / 13 days post-FTM
C. difficile infection patient 3, 28 days post-FTM / 15 days pre-FTM
C. difficile infection patient 3, 28 days post-FTM / 20 days post-FTM
C. difficile infection patient 3, 28 days post-FTM / 7 days post-FTM
C. difficile infection patient 3, 28 days post-FTM / Donor
C. difficile infection patient 3, 36 days post-FTM / 28 days post-FTM
C. difficile infection patient 3, 68 days post-FTM / 28 days post-FTM
C. difficile infection patient 3, 90 days post-FTM / 28 days post-FTM
Children, Mother secretor / Mother non-secretor
Children, Secretor / Non-secretor
China / Korea
China / Malawi
China / Peru
China / USA
China / Venezuela
China, After 2 weeks / Baseline
China, Urban / Rural
Chubu / Hokkaido
Chubu / Kanto
Chubu / Tohoku
Chugoku Shikoku / Chubu
Chugoku Shikoku / Hokkaido
Chugoku Shikoku / Kansai
Chugoku Shikoku / Kanto
Chugoku Shikoku / Tohoku
Ciprofloxacin / Control
Clostridia phase / Bacilli phase
Clostridia phase / Gammaproteobacteria phase
Colon polyps / Normal
Colorectal adenoma / Normal
Colorectal cancer / Normal
Consensus molecular subtypes 2 / Consensus molecular subtypes 1
Consensus molecular subtypes 3 / Consensus molecular subtypes 1
Consensus molecular subtypes 3 / Consensus molecular subtypes 2
Constipated after lubiprostone / Normal
Constipated before lubiprostone / Normal
Crohn's disease / Normal
Crohn's disease / Ulcerative colitis
Crohn's disease Active / Normal
Crohn's disease active onset / Normal
Crohn's disease Active presurgery / Normal
Crohn's disease in colon / Normal
Crohn's disease in ileum / Normal
Crohn's disease induction of remission treatments, Responders / Non-responders
Crohn's disease moderate / Normal
Crohn's disease severe / Normal
Crohn's disease, Active / Active onset
Crohn's disease, Active presurgery / Active
Crohn's disease, Active presurgery / Active onset
Crohn's disease, FUT2+/- / FUT2+/+
Crohn's disease, FUT2-/- / FUT2+/+
Crohn's disease, FUT2-/- / FUT2+/-
Cystic fibrosis / Normal
Day Hospital / Community
Denmark / China
Denmark / Malawi
Denmark / Peru
Denmark / USA
Denmark / Venezuela
Diarrheal Phase 2 / Diarrheal Phase 1
Diarrheal Phase 3 / Diarrheal Phase 1
Diarrheal Phase 4 / Diarrheal Phase 1
Digoxin / Control
During the first ciprofloxacin course / Before ciprofloxacin
During the first week post-first ciprofloxacin / Before ciprofloxacin
During the first week post-second ciprofloxacin / Before ciprofloxacin
During the second ciprofloxacin course / Before ciprofloxacin
Exclusively breast-fed children, Mother secretor / Mother non-secretor
Female / Male
France / China
France / Denmark
France / Malawi
France / Peru
France / Russia
France / Spain
France / Sweden
France / USA
France / Venezuela
Gammaproteobacteria phase / Bacilli phase
Habitual diet+Resistant starch / Habitual diet
HIV negative, Men sex with men / Men sex with women
Hodgkin lymphoma / Normal
Human Microbiome Project participants / Korean twins
In the interim period between ciprofloxacin courses / Before ciprofloxacin
Infant 1 month / Mother 1 week prior to delivery
Infant 1 week / Mother 1 week prior to delivery
Infant 1 year / Mother 1 week prior to delivery
Infant 3 months / Mother 1 week prior to delivery
Infant 7 months / Mother 1 week prior to delivery
Infant with HLA-DQ2 / Infant without HLA-DQ2/8
Intervention formula / Placebo formula
Irritable bowel syndrome-constipation / Normal
Japan / Austria
Japan / China
Japan / Denmark
Japan / France
Japan / Korea
Japan / Malawi
Japan / Peru
Japan / Russia
Japan / Spain
Japan / Sweden
Japan / USA
Japan / Venezuela
Kanamycin / Control
Kansai / Chubu
Kansai / Hokkaido
Kansai / Kanto
Kansai / Tohoku
Kanto / Hokkaido
Kanto / Tohoku
Kyushu / Chubu
Kyushu / Chugoku Shikoku
Kyushu / Hokkaido
Kyushu / Kansai
Kyushu / Kanto
Kyushu / Tohoku
Long-stay / Community
Long-stay / Day Hospital
Long-stay / Rehabilitation
Longevity village communities 40-69 year / Urbanized town communities 40-69 year
Longevity village communities 40-69 year / Urbanized town communities Children
Longevity village communities > 70 year / Longevity village communities 40-69 year
Longevity village communities > 70 year / Urbanized town communities 40-69 year
Longevity village communities > 70 year / Urbanized town communities Children
Madagascar / Central African Republic
Male / Female
Matses / Norman
Monozygotic twin TS29 / Monozygotic twin TS28
Mother 1 year after delivery / Mother 1 week prior to delivery
Multiple kidney stones / Normal
Multiple sclerosis / Crohn's disease
Multiple sclerosis / Normal
Multiple sclerosis / Ulcerative colitis
Nizatidine / Control
Nonalcoholic steatohepatitis / Normal
Nonalcoholic steatohepatitis / Obese
Norfloxacin / Control
Obese / Normal
Obese patients underwent Roux-en-Y gastric bypass, 1 year / Baseline
Obese patients underwent Roux-en-Y gastric bypass, 3 months / Baseline
Other colorectal conditions / Colorectal adenoma
Other colorectal conditions / Normal
Peru / Malawi
Peru / Venezuela
Pervasive developmental disorder not otherwise specified / Normal
pH4 / pH7
pH5 / pH7
Phenacetin / Control
Polydextrose / No supplemental fiber
Post ciprofloxacin / Before ciprofloxacin
Post-exclusive enteral nutrition / Pre-exclusive enteral nutrition
Postmenopausal breast cancer / Normal
Premenopausal breast cancer / Normal
Probiotic intervention / Control
Probiotic, After / Before
Proton pump inhibitors, After / Before
Proton pump inhibitors, After / On
Proton pump inhibitors, On / Before
Recovery Phase 2 / Recovery Phase 1
Recovery Phase 3 / Recovery Phase 1
Rectal cancer / Normal
Rehabilitation / Community
Rehabilitation / Day Hospital
Rheumatoid arthritis / Crohn's disease
Rheumatoid arthritis / Multiple sclerosis
Rheumatoid arthritis / Normal
Rheumatoid arthritis / Ulcerative colitis
Russia / China
Russia / Denmark
Russia / Malawi
Russia / Peru
Russia / Spain
Russia / USA
Russia / Venezuela
Schistosomiasis, Positive / Negative
Severely stunted / Moderately stunted
Soluble corn fiber / No supplemental fiber
Soluble corn fiber / Polydextrose
Spain / China
Spain / Denmark
Spain / Malawi
Spain / Peru
Spain / USA
Spain / Venezuela
Stunted / Nonstunted
Subsequent months / First month post-partum
Sulfasalazine / Control
Summer / Winter
SunGold kiwifruit, 12 weeks / Baseline
SunGold kiwifruit, 6 weeks / Baseline
Sweden / China
Sweden / Denmark
Sweden / Malawi
Sweden / Peru
Sweden / Russia
Sweden / Spain
Sweden / USA
Sweden / Venezuela
Tacrolimus, Dose escalation / Dose stable
Tetracycline / Control
Tetramisole / Control
Thyroid carcinoma / Normal
Tohoku / Hokkaido
Tunapuco / Matses
Tunapuco / Norman
TUW / Khentii
Type 1 diabetes / Normal
Type 2 diabetes / Normal
Ulan Bator / Khentii
Ulan Bator / TUW
Ulcerative colitis / Crohn's disease
Ulcerative colitis / Normal
Ulcerative colitis with FMT / Donor
Urbanized town communities 40-69 year / Urbanized town communities Children
USA / Amerindians
USA / China
USA / Korea
USA / Malawi
USA / Peru
USA / Venezuela
UTI patients, Adult household / Control
UTI patients, Ciprofloxacin / Control
UTI patients, Fosfomycin / Control
UTI patients, Nitrofurantoin / Control
Venezuela / Malawi
Weaned-3 years / Preweaning
Weaned-3 years / Weaning
Weaning / Preweaning
Women with previous gestational diabetes / Normal
Taxon level
Family
Genus
No rank
Species
Log2Ratio
>
=
<
Filter
Download
Detail
Taxon
Condition
Log2Ratio
P
value
k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Eubacteriaceae
Colorectal cancer / Normal
-0.992
<0.001
Loading...
k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Eubacteriaceae
Day Hospital / Community
2.273
<0.001
Loading...
k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Eubacteriaceae
During the first week post-first ciprofloxacin / Before ciprofloxacin
-1.048
<0.001
Loading...
k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Eubacteriaceae
During the first week post-second ciprofloxacin / Before ciprofloxacin
0.276
<0.001
Loading...
k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Eubacteriaceae
Long-stay / Community
2.306
<0.001
Loading...
k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Eubacteriaceae
Long-stay / Day Hospital
0.033
<0.001
Loading...
k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Eubacteriaceae
Long-stay / Rehabilitation
2.228
<0.001
Loading...
k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Eubacteriaceae
Rehabilitation / Community
0.078
<0.001
Loading...
k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Eubacteriaceae
Rehabilitation / Day Hospital
-2.195
<0.001
Loading...
k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Eubacteriaceae
Type 1 diabetes / Normal
0.117
<0.001
Loading...
Showing 1 to 10 of 703 entries
,
10
20
50
100
entries per page
<
1
2
3
4
5
...
71
>
